Research reading
Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale demand and the Netherlands (NLD) to Germany (DEU) lane
Germany (DEU) reported $783.2M of medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale imports in 2024. Netherlands (NLD) accounted for 0.7% of the observed market and reported $5.2M in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +6.5% buyer growth and +14.2% exporter growth. The page separates reported values from projections and indicators.
